Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' Deficiency

v2.4.0.6
Consolidated Statements of Changes in Shareholders' Deficiency (USD $)
 12 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
Common Stock
Dec. 31, 2009
Common Stock
Dec. 31, 2011
Additional paid in capital
Dec. 31, 2010
Additional paid in capital
Dec. 31, 2011
Accumulated Deficit
Dec. 31, 2010
Accumulated Deficit
Beginning balance, Shares     44,749,999 44,749,999        
Beginning balance, Value $ (589,200) $ (226,356) $ 44,750 $ 44,750 $ 72,217 $ 115,248 $ (706,167) $ (386,354)
Shares issued for acquisition, Shares     8,331,396          
Shares issued for acquisition, Value 2,000,000   8,331   1,991,669      
Proceeds from sale of common stock, Shares     955,000          
Proceeds from sale of common stock, Value 705,000   955   704,045      
Shares issued to extend maturity date of convertible notes payable, Shares     112,500          
Shares issued to extend maturity date of convertible notes payable, Value 56,250   113   56,137      
Shares issued upon conversion of convertible note payable, Shares     1,018,356          
Shares issued upon conversion of convertible note payable, Value 509,178   1,018   508,160      
Shares issued for liquidated damages, Shares     13,914          
Shares issued for liquidated damages, Value 6,957   14   6,943      
Distribution   (43,031)       (43,031)    
Net loss for year (5,457,310) (319,813)         (5,457,310) (319,813)
Ending balance, Shares     55,181,165 44,749,999        
Ending balance, Value $ (2,769,125) $ (589,200) $ 55,181 $ 44,750 $ 3,339,171 $ 72,217 $ (6,163,477) $ (706,167)